UNIVERSITY OF SOUTHERN CALIFORNIA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1880-01-01

Employees: 10K

Market Cap: -

Website: http://startusc.com

Clinical Trials

Multi-frequency Bioelectrical Impedance for Estimating Total Body Water by Deuterium Dilution

Completed

Conditions: Total Body Water Assessment

Interventions: Other: observation

First Posted Date: 2012-05-30

Last Posted Date: 2012-05-30

Lead Sponsor: University of Southern California

Target Recruit Count: 25

Registration Number: NCT01607229

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Testosterone Administration and ACL Reconstruction in Men

Phase 3

Completed

Conditions: Trauma
Muscle Atrophy
ACL Reconstruction
Osteoarthritis

Interventions: Drug: Placebo
Drug: Testosterone

First Posted Date: 2012-05-10

Last Posted Date: 2022-03-02

Lead Sponsor: University of Southern California

Target Recruit Count: 14

Registration Number: NCT01595581

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

Exploratory Study to Assess Clinical Response to Gilenya® (Fingolimod) in Hispanics With RRMS

Completed

Conditions: Multiple Sclerosis

First Posted Date: 2012-05-07

Last Posted Date: 2018-05-03

Lead Sponsor: University of Southern California

Target Recruit Count: 51

Registration Number: NCT01592097

Locations: 🇺🇸
Keck School of Medicine of the University of Southern Calfornia, Los Angeles, California, United States

Clamped or Unclamped Surgery in Treating Patients With Kidney Cancer

Not Applicable

Terminated

Conditions: Recurrent Renal Cell Cancer

Interventions: Procedure: robot-assisted laparoscopic surgery

First Posted Date: 2012-03-08

Last Posted Date: 2015-03-27

Lead Sponsor: University of Southern California

Target Recruit Count: 28

Registration Number: NCT01547676

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Dalteparin, Lenalidomide, and Low-Dose Dexamethasone in Treating Patients With Previously Untreated Multiple Myeloma

Phase 2

Terminated

Conditions: Stage I Multiple Myeloma
Stage II Multiple Myeloma
Stage III Multiple Myeloma

Interventions: Drug: dalteparin
Drug: lenalidomide
Drug: dexamethasone
Other: laboratory biomarker analysis

First Posted Date: 2012-01-26

Last Posted Date: 2017-11-29

Lead Sponsor: University of Southern California

Target Recruit Count: 13

Registration Number: NCT01518465

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Intra-arterial Magnesium Administration for Acute Stroke

Phase 1

Terminated

Conditions: Acute Stroke

Interventions: Drug: Magnesium Sulfate

First Posted Date: 2012-01-02

Last Posted Date: 2017-08-28

Lead Sponsor: University of Southern California

Target Recruit Count: 4

Registration Number: NCT01502761

Locations: 🇺🇸
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals, Los Angeles, California, United States
🇺🇸
University of Southern California University and LA County Hospitals, Los Angeles, California, United States

Endovascular Magnesium Sampling in Acute Stroke

Not Applicable

Terminated

Conditions: Acute Stroke

Interventions: Other: endovascular sampling

First Posted Date: 2012-01-02

Last Posted Date: 2017-08-01

Lead Sponsor: University of Southern California

Target Recruit Count: 2

Registration Number: NCT01502748

Locations: 🇺🇸
University California Los Angeles: Ronald Reagan and Santa Monica Hospitals, Los Angeles, California, United States
🇺🇸
University of Southern California University and LA County Hospitals, Los Angeles, California, United States

Transrectal Ultrasound (TRUS) in Finding Tumors During Robotic-Assisted Laparoscopic Surgery

Not Applicable

Completed

Conditions: Prostate Cancer

Interventions: Procedure: ultrasound imaging
Procedure: robot-assisted laparoscopic surgery

First Posted Date: 2011-12-19

Last Posted Date: 2014-01-29

Lead Sponsor: University of Southern California

Target Recruit Count: 11

Registration Number: NCT01495130

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Cabazitaxel Plus Prednisone With Octreotide For Castration-Resistant Prostate Cancer (CRPC) Previously Treated With Docetaxel

Phase 2

Terminated

Conditions: Recurrent Prostate Cancer
Stage I Prostate Cancer
Diarrhea
Stage IIB Prostate Cancer
Hormone-resistant Prostate Cancer
Stage IIA Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer

Interventions: Drug: cabazitaxel
Drug: prednisone
Drug: octreotide pamoate
Other: questionnaire administration
Drug: octreotide acetate

First Posted Date: 2011-11-10

Last Posted Date: 2014-11-24

Lead Sponsor: University of Southern California

Target Recruit Count: 9

Registration Number: NCT01469338

Locations: 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

Transcranial Direct-Current Stimulation in Childhood Dystonia

Phase 2

Conditions: Childhood Onset Dystonias

Interventions: Device: TDCS (Transcranial Direct-current Stimulation)
Device: sham TDCS (Transcranial Direct-current Stimulation)

First Posted Date: 2011-10-27

Last Posted Date: 2014-05-22

Lead Sponsor: University of Southern California

Target Recruit Count: 100

Registration Number: NCT01460771

Locations: 🇺🇸
University of Southern California, Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy